Myomo Inc. (AMEX:MYO) will be discussing 3Q20 financial results with the investment community.on 10th November 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.myomo.com
Earnings Expectation
Myomo Inc. is reporting third quarter financial results on Tuesday 10th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, MYO is expected to report 3Q20 loss of $ 1.05 per share from revenue of $ 1.17 million.
For the full year, analysts anticipate top line of $ 5.12 million, while looking forward to loss of $ 4.88 per share bottom line.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patients weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.